Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.
Original analysis with revenues, growth rates, market shares, opinion and discussions
You will find revenue forecasts, growth rates, market shares, a SWOT/STEP review, opinions from our survey and discussions of technologies and companies. We provide 76 tables and charts and three research interviews (shown in the accompanying lists).
Biomarkers: Technological and Commercial Outlook 2011-2021 shows you opportunities, challenges and revenue forecasts
Our report gives you the following advantages:
• You will discover revenue forecasts to 2021 for the world biomarkers market and its main components, seeing where the highest revenue growth will occur
• You will appraise the future of biomarkers research from scientific, technological and commercial perspectives, seeing R&D trends
• You will receive revenue forecasts for the leading therapeutic areas for biomarker technologies - oncology, cardiovascular diseases and CNS disorders - to 2021
• You will see forecast revenues for genomics, proteomics and bioinformatics to 2021
• You will find discussions of biomarker research and assess the importance of that work for patient stratification and targeted therapies
• You will receive revenue forecasts for the leading national markets for biomarkers to 2021 - the US, the UK, Canada, Germany, France, Spain, Italy, Japan, China and India - seeing growth prospects
• You will investigate activities of leading companies developing biomarkers
Copyright©2010 PR Newswire.
All rights reserved